Kuros Biosciences AG Stock Swiss Exchange
Stocks
CH0011025217
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 08-14 | Kuros Biosciences AG, H1 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Kuros Biosciences AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 849M 1.04B 902M 772M 1.45B 100B 1.47B 9.96B 3.9B 50.06B 3.92B 3.84B 167B | P/E 2026 * |
104x | P/E 2027 * | 44.5x |
|---|---|---|---|---|---|
| Enterprise Value | 838M 1.03B 891M 762M 1.43B 98.84B 1.45B 9.83B 3.85B 49.43B 3.87B 3.79B 165B | EV / Sales 2026 * |
5.03x | EV / Sales 2027 * | 3.61x |
| Free-Float |
71.26% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kuros Biosciences AG
| Manager | Title | Age | Since |
|---|---|---|---|
Christopher Fair
CEO | Chief Executive Officer | 56 | 12/10/2023 |
Joost de Bruijn
CEO | Chief Executive Officer | 60 | 04/12/2017 |
Daniel Geiger
DFI | Director of Finance/CFO | - | 17/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 14/06/2018 | |
Joost de Bruijn
BRD | Director/Board Member | 60 | 14/06/2018 |
Oliver Walker
BRD | Director/Board Member | 57 | 14/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.17% | +3.62% | +70.94% | +109.68% | 73.25B | |
| +1.73% | +16.15% | +51.73% | +93.89% | 61.95B | |
| +0.01% | -2.98% | +1.06% | +491.90% | 28.02B | |
| +5.24% | +5.33% | +57.01% | +17.77% | 24.15B | |
| +0.82% | -0.52% | -17.97% | -16.35% | 23.01B | |
| -0.71% | +5.26% | +241.94% | +427.03% | 18.35B | |
| 0.00% | +5.57% | +39.57% | -14.30% | 19.46B | |
| +3.83% | +2.65% | +25.00% | +592.85% | 15.92B | |
| +1.62% | +3.59% | +40.82% | +152.01% | 12.96B | |
| Average | +1.41% | +1.24% | +56.68% | +206.06% | 30.79B | |
| Weighted average by Cap. | +1.21% | +3.43% | +56.05% | +168.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 167M 205M 177M 151M 285M 19.65B 289M 1.95B 766M 9.83B 770M 753M 32.73B | 224M 275M 238M 203M 382M 26.36B 388M 2.62B 1.03B 13.19B 1.03B 1.01B 43.92B |
| Net income | 9.32M 11.47M 9.91M 8.47M 15.93M 1.1B 16.17M 109M 42.85M 550M 43.07M 42.13M 1.83B | 21.65M 26.64M 23.01M 19.68M 37.01M 2.55B 37.55M 254M 99.53M 1.28B 100M 97.86M 4.25B |
| Net Debt | -10.7M -13.16M -11.37M -9.72M -18.28M -1.26B -18.55M -125M -49.17M -631M -49.42M -48.34M -2.1B | -41.26M -50.77M -43.85M -37.5M -70.52M -4.86B -71.56M -484M -190M -2.43B -191M -186M -8.1B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
